RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(43 sites)

United States

Altimmune Clinical Study Site, Peoria, Arizona

Altimmune Clinical Study Site, Tucson, Arizona

Altimmune Clinical Study Site, Tuscon, Arizona

Altimmune Clinical Study Site, North Little Rock, Arkansas

Altimmune Clinical Study Site, Fresno, California